Eli Lilly and Company (LLY) R&D US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 6 931 | 7 191 | 9 313 | 10 991 | 13 338 | 14 114 | |||
| Changes by years, y/y, % | +14% | +4% | +30% | +18% | +21% | +17.0% | |||
Eli Lilly and Company. R&D, bln rub
Eli Lilly and Company. R&D, changes, %
Eli Lilly and Company. R&D, sum by quarters, bln rub
Eli Lilly and Company (LLY) R&D US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| R&D, bln rub | 2 734 | 3 336 | 3 466 | 3 802 | 3 510 | 14 114 | ||
| Changes by years, y/y, % | +8% | +23% | +27% | +26% | +28% | |||
| Changes by quarters, q/q, % | -10% | +22% | +4% | +10% | -8% | |||